| Status: Under consideration by AWMSG Scrutiny Panel | |
For the off label treatment of severe treatment-resistant morphoea (localised scleroderma) in adults and children 2 years and older. |
|
Medicine details |
|
| Medicine name | abatacept (Orencia) |
| Formulation | solution for injection; powder for solution for infusion |
| Reference number | 11080 |
| Indication | As above |
| BNF chapter | Musculoskeletal & joint diseases |
| Assessment type | Under consideration |
| Status | Under consideration by AWMSG Scrutiny Panel |
| Scrutiny Panel meeting date | 15/10/2026 |